| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 9e-07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 6e-06 |